Parkman Healthcare Partners LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Parkman Healthcare Partners LLC
- $687 Million
- Q4 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 514,273 shares of RVPH stock, worth $822,836. This represents 0.13% of its overall portfolio holdings.
Number of Shares
514,273
Previous 512,202
0.4%
Holding current value
$822,836
Previous $737,000
20.62%
% of portfolio
0.13%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding RVPH
# of Institutions
51Shares Held
7.83MCall Options Held
628KPut Options Held
338K-
Israel Englander Millennium Management LLC | New York, Ny1.8MShares$2.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.22 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.36MShares$2.18 Million0.03% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.06MShares$1.69 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$498,7210.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $32.7M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...